provider_review · verified 2026-08-07

MyDrHank review

The "$137" is a twelve-month prepay — month to month it is $199

The NAD+ lander leads with "Starting at $137/month", but the plan ladder behind it prices the nasal spray at $199 monthly and only reaches $137 as the per-month equivalent of a $1,644 year paid up front.

How this site makes money

Plain version: a handful of the outbound links here are affiliate or referral links. Follow one, start a treatment or buy a product, and we may earn a commission — your price stays exactly the same. That money pays for the research, and what we write about any product — and the price you pay — are the same either way. Want the specifics? Read the full disclosure.

visit MyDrHank

at_a_glance

price: "Starting at $137/month", printed in the nav and the hero of the NAD+ lander, with the qualifier "Final pricing depends on the protocol and dose prescribed" directly beneath it.
what you pay: $199/month for the nasal spray and $225/month for the injection if you pay month to month. The nasal ladder is $507 a quarter ($169/mo), $913 for six months ($152/mo) and $1,644 for a year ($137/mo); the injection ladder is $574 ($191/mo), $1,033 ($172/mo) and $1,859 ($155/mo).
pharmacy: Not named. The lander says only "a licensed U.S. compounding pharmacy" and publishes no 503A or 503B designation for the NAD+ line, so there is no license a reader can look up. It does carry a real compounding disclosure in its own words — NAD+ dispensed here "is a compounded medication prepared by a state-licensed U.S. compounding pharmacy. Compounded drugs are not FDA-approved and have not been evaluated by the FDA for safety, efficacy, or quality" — which is more than several better-known sellers here manage. The operating entity is Dr. Hank, LLC, named in the site's own privacy policy and terms of use. Earlier reporting elsewhere attached three specific dispensing pharmacies to this brand; none of those names appears anywhere on the site today, in rendered text or in the application bundle behind it, so this review credits none of them.
states: "Available in select states" is as specific as the consumer pages get — no list, and eligibility is settled during intake. The one concrete exclusion list we can point to comes from the company's own affiliate terms rather than its storefront: Kansas, Louisiana, Mississippi, New Mexico, North Dakota and West Virginia are excluded. Treat that as the floor, not the whole map.
on our index: Ranked #12 of 34 on our NAD+ provider index.

verdict

The short version

MyDrHank sells physician-prescribed compounded NAD+ two ways — a daily nasal spray or a weekly subcutaneous injection — and the clinical wrapper around it is better than most providers here: a 3-minute intake, a stated 24-hour clinician review, free shipping, no bloodwork required to start, and a compounding disclosure printed on the lander itself rather than buried in a footer. What the lander does not do is price honestly. "Starting at $137/month" is the cheapest cell of the cheapest route on the longest commitment: the nasal spray is $199 month to month, $169 on a $507 quarter, $152 on a $913 six months and $137 only on a $1,644 year paid in one go, while the injection runs $225 month to month. Read the number as "$199, or $137 if you buy a year" and it becomes a fair mid-market price. Read it the way the page presents it and you are budgeting for a plan that does not exist. NAD+ is also one shelf of six here — weight loss, longevity, peptides and NAD+, sexual health, hair and strength — not the house specialty.

evidence

What the evidence for this route shows

Compounded NAD+ is not an FDA-approved product, and the route sold here has no randomized human trial behind it: there is no published study showing that subcutaneous or intranasal NAD+ raises blood NAD+ in people, let alone that it improves energy, focus or any aging endpoint. What the clinical literature actually supports is the oral precursor NR, which does raise blood NAD+ in controlled trials — a different molecule by a different route. MyDrHank's own marketing illustrates the gap neatly. Its NAD+ nasal spray page carries a mechanism section headed by a "6x increase in whole blood NAD+ after 12 weeks of supplementation" statistic, and the citation printed under it is Igarashi et al., npj Aging 2022 — a randomized, placebo-controlled trial of ORAL nicotinamide mononucleotide in healthy older men. That is a real trial, and it is evidence for swallowing NMN capsules. It is not evidence that spraying NAD+ into a nostril reaches the bloodstream, and no study cited on the page is. To its credit, the same product page's small print concedes the point directly: "Clinical evidence for nasal and injectable NAD+ delivery is limited."

pricing

What it actually costs

advertised: "Starting at $137/month", printed in the nav and the hero of the NAD+ lander, with the qualifier "Final pricing depends on the protocol and dose prescribed" directly beneath it.
you pay: $199/month for the nasal spray and $225/month for the injection if you pay month to month. The nasal ladder is $507 a quarter ($169/mo), $913 for six months ($152/mo) and $1,644 for a year ($137/mo); the injection ladder is $574 ($191/mo), $1,033 ($172/mo) and $1,859 ($155/mo).
the catch: A prepay ladder presented as a starting price, and the ladder is not on the page. $137 is not a plan you can buy — it is $1,644 for twelve months of nasal spray, divided by twelve, quoted as though it were the entry point for the whole NAD+ line. The lander shows that single figure and nothing else: the month-to-month rate appears nowhere on it, and neither do the quarterly or six-month tiers. We read the four-tier ladder out of the product catalog behind the funnel, in the site's own JavaScript bundle, because that is the only place it exists. A reader who commits at "$137" and then takes the injection month to month pays $225 — 64% above the figure that sold them.

Other money you will meet

Free physician consultation with the first order, advertised as "limited time" rather than standing policy
Shipping is included and ships free from the compounding pharmacy in plain packaging
Cash-pay only — no insurance is billed, so none of this is reimbursable
"Final pricing depends on the protocol and dose prescribed", so the ladder above is the published floor rather than a quote

source :: read at mydrhank.com on 2026-08-07, in a browser that runs JavaScript.

fit

Who this is and is not for

Buy it if

You already intend to stay on NAD+ for a year and would rather pay $1,644 once than $199 twelve times
You want the choice of nasal spray or weekly injection from one provider rather than being sold a single route
You want to start without bloodwork, an in-person visit or an insurance conversation
You want the compounded-drug caveat stated by the seller rather than discovered later

Look elsewhere if

You want a month-to-month price that matches the number on the page — here it is $62 higher for the spray
You want a named compounding pharmacy or a published 503A/503B designation
You need to confirm your state is served before you hand over an intake — no list is published
You want evidence that the route works: neither intranasal nor subcutaneous NAD+ has a human trial behind it

included

What is inside the price

consult: Yes. A 3-minute online intake is reviewed by a U.S. board-certified clinician within a stated 24 hours, and a free physician consultation is advertised with the first order. Eligibility is determined by the clinician after that review.
labs: Not required, and unusually the site says so outright rather than staying silent: "no office visits, no insurance, no bloodwork required to start." Convenient, and the same trade every seller here makes — nobody is measuring a baseline NAD+ level.
follow-ups: Not itemized on the NAD+ lander. The clinician sets the protocol and the format at intake; no follow-up cadence or dose-adjustment policy is published.
human support: None advertised beyond the prescribing clinician — no nurse line, dietitian or coach is offered on this line.
supplies: Not itemized for the injection on the NAD+ lander; the nasal format needs none. The product pages describe dosing (1–2 sprays per nostril daily, or a subcutaneous injection 2–3 times a week) without listing what ships with it.
shipping: Free, "shipped free from a licensed U.S. compounding pharmacy in plain packaging."

the_knock

What they would rather you skipped

The headline price is a plan you cannot buy, and the plan you can buy is not on the page. "Starting at $137/month" appears in the navigation bar, in the hero, in the closing call to action and on the mobile sticky button of the NAD+ lander — four times on one page — and the number is the per-month equivalent of a $1,644 twelve-month prepay, the cheapest cell of the cheapest route on the longest commitment. The month-to-month rate is printed nowhere on that lander. Buy the nasal spray month to month and it is $199; buy the injection month to month and it is $225. We only have those figures because we pulled the product catalog out of the site's own JavaScript bundle; a reader who does what readers do — read the page — is shown one number, and it is the one that requires $1,644 up front. There is a sharper version of this. The same company's GLP-1 funnel answers the dose-pricing question in writing and answers it well — "the price stays the same at every dose — no surprise price increases", with "flat pricing that never changes on any dose" printed elsewhere on that page. That is exactly the promise a reader needs, and the NAD+ lander does not make it. It says the opposite: "Final pricing depends on the protocol and dose prescribed." The company knows how to guarantee dose-independent pricing, offers it on the product it is best known for, and withholds it here. We are paid when someone starts care through this page, which is the reason this paragraph is the longest one in the review.

And the rest

"Starting at $137/month" is a $1,644 annual prepay divided by twelve; month to month the spray is $199 and the injection $225
The lander advertises that prepay minimum and nothing else — the month-to-month rate is never shown on it, and the four-tier ladder is only reachable in the product catalog behind the funnel
The NAD+ lander explicitly does NOT promise dose-independent pricing, while the company's GLP-1 funnel explicitly does
No compounding pharmacy is named and no 503A/503B designation is published for the NAD+ line
"Available in select states" with no published list; the only exclusions we can cite come from the affiliate terms, not the storefront
The nasal spray's headline statistic and its supporting citation both come from a trial of oral NMN, not of a nasal spray
NAD+ is one of six product lines here, not a specialty — and we earn a commission when you start care through this page

tools

Work out your own number

NAD+ therapy cost calculator

visit MyDrHank

Every figure on this page was read on MyDrHank’s own site on 2026-08-07 in a browser that runs JavaScript, and prices change without notice. Compare it against the rest of the field on our NAD+ provider index, or read every provider review.

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.